Fluorine18CholineQualityChecker
Fluorine-18 Choline
Utility description: Fluorine-18 Choline
Fluorine-18 Choline Quality Checker — Fluorine-18 Choline for PET Oncology
ℹ️ Utility checks critical parameters of [18F]Fluorocholine:
• Radionuclidic purity (≥99.9%)
• Radiochemical purity (≥95%)
• Free Fluoride-18 impurity (≤5.0%)
• Precursor/Cold choline impurity (≤2.0%)
• Specific activity (≥50 GBq/μmol)
• Residual solvents (ethanol), pH, endotoxins, sterility
⚠️ CRITICAL: Free Fluoride-18 >5.0% → accumulation in bones, risk of false positives in bone metastasis detection!
Usage:
Fluorine18CholineQualityChecker.exe → demo mode (console output)
Fluorine18CholineQualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol
Example (sterility: 0=sterile, 1=contaminated):
F18-CHOL-2026-001,99.99,98.0,1.5,0.5,7.0,30.0,0,2,5.0,120.0
— WHY IS THIS NEEDED?
[18F]Fluorocholine is used for PET imaging of tumors with high phospholipid metabolism:
• Main application: Prostate cancer (localization of recurrences with rising PSA)
• Also used: Hepatocellular carcinoma, brain tumors
• F-18 Half-life: 109.7 minutes
⚠️ CRITICAL:
• Radiochemical purity ≥95% — ensures specific uptake in tumor tissue
• Free Fluoride ≤5.0% — [18F]fluoride is actively taken up by bone tissue. In prostate cancer staging, this is critical as bones are a common site for metastases. High background can mask small lesions.
• Specific activity ≥50 GBq/μmol — necessary to minimize pharmacological effect of choline
• Residual Solvents (Ethanol) — controlled per ICH Q3C
• pH 4.5–8.5 — physiological range
• Endotoxins ≤175 EU/vial — safety standard
• Sterility — MANDATORY
Key features:
• Specific control of free fluoride due to risk of bone artifacts
• Specific activity control
• Residual solvent check
Critical parameters:
• Radionuclidic purity: ≥99.9%
• Radiochemical purity: ≥95.0%
• Free Fluoride-18: ≤5.0%
• Precursor/Cold drug: ≤2.0%
• Specific activity: ≥50.0 GBq/μmol
• Ethanol: ≤10.0%
• pH: 4.5–8.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
💡 Usage tips:
1. Radiochemical purity and free fluoride content determined by TLC or HPLC
2. For TLC, systems such as acetonitrile/water are often used
3. Specific activity calculated from activity to molar amount ratio (HPLC-UV)
⚠️ Note: Unlike amyloid tracers where brain contrast is key, for choline it is critical to have no skeletal background for correct oncological staging.input.csv
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol F18-CHOL-2026-001,99.99,98.0,1.5,0.5,7.0,30.0,0,2,5.0,120.0 F18-CHOL-2026-002,99.95,94.0,6.5,1.0,6.8,100.0,0,5,8.0,40.0 F18-CHOL-2026-003,99.98,99.0,0.5,0.2,7.2,10.0,0,1,2.0,200.0
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of Fluorine18CholineQualityChecker for Fluorine-18 Choline.
Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of [18F]Fluorocholine:
- • Radionuclidic purity (≥99.9%)
- • Radiochemical purity (≥95%)
- • Free Fluoride-18 impurity (≤5.0%)
- • Precursor/Cold choline impurity (≤2.0%)
- • Specific activity (≥50 GBq/μmol)
- • Residual solvents (ethanol), pH, endotoxins, sterility
- ⚠️ CRITICAL: Free Fluoride-18 >5.0% → accumulation in bones, risk of false positives in bone metastasis detection!
- BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol
- Example (sterility: 0=sterile, 1=contaminated):
- ⚠️ CRITICAL:
- • Radiochemical purity ≥95% — ensures specific uptake in tumor tissue
- • Free Fluoride ≤5.0% — [18F]fluoride is actively taken up by bone tissue. In prostate cancer staging, this is critical as bones are a common site for metastases. High background can mask small lesions.
- • Specific activity ≥50 GBq/μmol — necessary to minimize pharmacological effect of choline
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with the exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation for Fluorine-18 Choline using input values, approved limits and domain rules. | High | Each input row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility. | High | Schema and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present. | High | A critical deviation causes FAIL or a separate critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall not use machine learning to decide conformance. | Medium | The result is based on explicit rules, thresholds and input values. |
| URS-007 | The utility shall preserve traceability between batch number, input values, applied rules and final status. | High | The output contains the batch identifier and the list of checked parameters. |
| URS-008 | The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators. | Medium | URS & FS, input.csv/output.json contract and test scenarios are supplied with the utility. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | F18-CHOL-2026-001 | Batch or lot identifier used for traceability. |
| 2 | RadionuclidicPurityPercent | string | 99.99 | Radionuclidic purity; a critical radiation-safety and impurity parameter. |
| 3 | RadiochemicalPurityPercent | string | 98.0 | Radiochemical purity; confirms the labelled chemical form and binding quality. |
| 4 | FreeFluoridePercent | string | 1.5 | Free radionuclide / unbound species; important for non-target uptake and toxicity. |
| 5 | PrecursorImpurityPercent | string | 0.5 | Controlled impurity or residual material. |
| 6 | pH | decimal | 7.0 | Solution pH; relevant for stability, compatibility and administration. |
| 7 | EndotoxinsEU | decimal | 30.0 | Bacterial endotoxins; critical for parenteral administration. |
| 8 | SterilityTest | flag / boolean | 0 | Sterility result; critical release parameter. |
| 9 | HeavyMetalsPPM | decimal | 2 | Elemental impurity / metal residue parameter. |
| 10 | ResidualEthanolPercent | string | 5.0 | Controlled input parameter used by the deterministic QC rules. |
| 11 | SpecificActivityGBqPerUmol | decimal | 120.0 | Radioactivity value used for release, decay or dose-related assessment. |
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeFluoridePercent,PrecursorImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ResidualEthanolPercent,SpecificActivityGBqPerUmol F18-CHOL-2026-001,99.99,98.0,1.5,0.5,7.0,30.0,0,2,5.0,120.0 F18-CHOL-2026-002,99.95,94.0,6.5,1.0,6.8,100.0,0,5,8.0,40.0 F18-CHOL-2026-003,99.98,99.0,0.5,0.2,7.2,10.0,0,1,2.0,200.0
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields and column count; report unknown or missing key fields. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Fluorine-18 Choline, including critical limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation. |
Example output.json
{
"utilityId": "fluorine18-choline-quality-checker",
"api": "Fluorine-18 Choline",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "F18-CHOL-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadionuclidicPurityPercent",
"value": "99.99",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "98.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "FreeFluoridePercent",
"value": "1.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "PrecursorImpurityPercent",
"value": "0.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH",
"value": "7.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "EndotoxinsEU",
"value": "30.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "SterilityTest",
"value": "0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": []
}
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| PQ-001 | User real batch/lot | Reviewed result with input.csv and output.json retained. |
QA/QC and change control
- Do not rename columns without updating the validator and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.
Included in packages
Andrology QC Suite
QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.
OpenCardiology QC Suite
QC package for cardiology medicines: antihypertensives, anticoagulants, antiplatelets, lipid-lowering and antiarrhythmic medicines plus supporting QC checks.
OpenPetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH isotope family: short-lived PET isotopes
F-18, C-11, N-13, O-15 and related PET production, release and imaging workflows.
OpenRPH organ/system: bone and musculoskeletal
Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.
OpenRPH organ/system: brain and CNS
Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH use case: PET/SPECT oncology diagnostics and receptor imaging
F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.
OpenRPH workflow: generators and isotope purity
Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
OpenUrology QC Suite
QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.
Open